The Week in Review: Nov 30 – Dec 7, 2018

Friday, Dec 7, 2018 News Recap: Renally-Impaired Patients with Chronic Hepatitis B Virus Infection Find Success with Low Dose of TDF A low dose of tenofovir disoproxil fumarate (TDF) may help to preserve renal function and maintain viral suppression in patients with chronic hepatitis B virus infection, even those with advanced liver disease, according to new research. Join Us to Honour & Remember Our Friend Phil Wilkin On Friday December 14,...

Renally-Impaired Patients with Chronic Hepatitis B Virus Infection Find Success with Low Dose of TDF

A low dose of tenofovir disoproxil fumarate (TDF) may help to preserve renal function and maintain viral suppression in patients with chronic hepatitis B virus infection, even those with advanced liver disease, according to new research. TDF (Viread, Gilead) is currently approved for the treatment of chronic hepatitis B virus infection in adults and pediatric patients who are 12 years and older. Although the treatment is effective in inhibiting hepatitis